Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 24, 2021

View Archived Issues

British Pakistani genomics study illustrates need for diversity

Engineered AAV capsids allow specific transgene expression in the brain of mouse and marmoset

Alphataxin increases CD4+ tumor-infiltrating T cells and suppresses renal cell cancer in mice

Dual PI3K/BRD4 inhibitors divulged by Monash University, Peter MacCallum Cancer Centre

CSIPI and Shanghai Zhongze Therapeutics patent dopamine D2/D3/5-HT2A receptor antagonists

Trinuero, DGMIF identify SERT, NET and DAT inhibitors

Janssen Pharmaceutica synthesizes new Mcl-1 inhibitors

New USP30 inhibitors identified at Mission Therapeutics

Anti-CD47 antibody ADG-153 shows promising preclinical data for cancer immunotherapy

Gene expression of extramedullary multiple myeloma samples points to new targets

Evusheld retains neutralizing activity against Omicron variant

WestVac BioPharma's COVID-19 vaccine shows high titer neutralizing antibodies against Omicron

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...